Trial
NCT07191912
Confirmatory Study of Govorestat in CMT-SORD
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Applied Therapeutics, Inc.
Collaborators
—
Condition
Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD)
Intervention
Govorestat
Why stopped
The study was withdrawn prior to enrollment as the sponsor decided not to proceed with study initiation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-29